Hybrid and decentralized clinical trials are nothing new to Elligo. Our tailored solutions have been bringing research directly to patients since 2016! By adapting to your protocol’s unique needs, we ensure that your clinical research meets your goals anywhere your patients are. Connect to learn more about how Elligo can recruit, enroll, and retain participants for your next trial: https://lnkd.in/efGA3fV #DecentralizedTrials #DCT #ClinicalTrials #ClinicalResearch
About us
Elligo Health Research is an integrated research organization founded to bridge the gap between cutting-edge clinical trials and the patients who need them—an idea that sparked when our founder's barber couldn't access a promising treatment. By embedding research into routine care, Elligo empowers physicians to offer trials to their own patients, expanding access, improving diversity, and reducing barriers through additional travel and retention support services. Sponsors and CROs benefit from a nationwide network of research-ready sites—traditional and decentralized— backed by EHR data integration and proven recruitment strategies. With flexible service models, Elligo supports each site’s unique needs, from infrastructure and staffing to full-service trial operations. Our mission is to accelerate clinical research and bring life-changing therapies to more people, faster.
- Website
-
https://www.elligohealthresearch.com/
External link for Elligo Health Research
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Specialties
- Study initiation, Investigator support, Site development, Research Services, Biotech Research, Clinical Trial Study Services, Patient Travel Services, Patient Recruitment, and Financial Management Services
Locations
-
Primary
Get directions
11612 Bee Cave Rd
Austin, Texas 78738, US
Employees at Elligo Health Research
Updates
-
In Chicago for #ADLM? Stop by the #DxPx Startup City to connect with Brandon Cormier and Chris Pepper to chat about what Elligo can do for your next diagnostics study.
Today’s the Day - #DxPx Startup City at #ADLM Kicks Off! 🚀 The show floor is set, the startups are ready, and the conversations are waiting to be flowing! While all startup booths are sold out, you can still be part of the action through our Virtual Partnering Platform, open now through September 5th. 📍 Need help navigating the venue? Check out our# DxPx Floor Plan to find all the amazing startups and partners on-site! 🎟️ Grab your virtual partnering ticket and start connecting today. Join our virtual partnering to schedule 1:1 meetings! Presented by: We Venture Capital – the CVC arm of Werfen, investing in diagnostics innovation worldwide. DxPx Angels – a passionate community of investors driving breakthroughs in precision medicine. Let’s make this DxPx the most impactful yet – see you online or on the floor! Meet and connect with our amazing exhibitors: Amadix, Cytophenix, Genomadix, MLA Diagnostics, Hylid Diagnostics Inc, Surfix, RICOVR Healthcare, Genomill , Elligo Health Research, Brand Institute, Clinical Design Technologies Ltd., VectorDx, Genomtec SA, NADMED Ltd., Axithra, Annaida Technologies , STRATEC SE, NBCL - Novel Biomarkers Catalyst Lab, BiopSense Oy, Ad Astra Diagnostics, Inc., Prolight Diagnostics, Macula Vision Systems, Loop Dx, Signal Bioscience, Ginolis, Bacteromic, NOWDiagnostics | NOWDx, Scope Biosciences B.V.Pando Bioscience (YC W23)
-
-
Elligo is proud to exhibit in #DxPx Startup City at the #ADLM Expo 2025, kicking off tomorrow in Chicago! Connect with our Chief Commercial Officer, Brandon Cormier, and Senior Director of IVD and MedTech Solutions, Chris Pepper, to explore how Elligo supports IVD companies with our flexible, decentralized clinical trial solutions. From analytical validation and clinical performance studies, we offer access to diverse patients and deep expertise in specimen collection. To learn more, stop by booth #260 or schedule a meeting with us here: https://lnkd.in/eaU4hrAF #DxPx #StartupCity #DCT #ADLM2025 #DecentralizedTrials
-
-
Will your team be in Chicago for #ADLM Expo 2025? Let's connect! Elligo's Brandon Cormier and Chris Pepper will be connecting with industry leaders in the #DxPx Startup City exhibit to talk about how Elligo's decentralized clinical trial solutions can deliver results for your next trial. Schedule a meeting with us now: https://lnkd.in/eaU4hrAF
Bridging healthcare and research - Elligo Health Research is accelerating access to clinical trials worldwide! Meet Elligo Health Research, a leading integrated research organization using real-world healthcare data and its proprietary IntElligo® technology to bring clinical trials directly to patients and physicians. As a #DxPx Startup City exhibitor at #ADLM Expo 2025, Elligo is transforming how diagnostics, therapeutics, and medical devices are developed - by enabling faster, more inclusive, and more efficient trials through its vast network of healthcare-first and research-ready sites. Join us in Chicago! 📍 McCormick Place Convention Center 📆 July 29–31, 2025 The Countdown is on! Don’t miss this unique networking opportunity at the heart of the action. Secure your spot now and connect with the future of diagnostics and health innovation!
-
-
At Elligo Health Research, we work side by side with sponsors and CROs to deliver vaccine trials that are both inclusive and efficient. In a previous vaccine study, we not only launched quickly but delivered 55.9% diversity for participants under the care of their trusted providers in our Elligo Site Network. Connect to explore how we can support your next vaccine trial: https://lnkd.in/efGA3fV #DiversityInResearch #VaccineTrials #ClinicalResearch #PatientAccess #ResearchAsCare #ElligoHealthResearch
-
Don't forget to join Elligo's Dr. Faith Holmes, M.D. tomorrow for a great discussion on supporting participants enrolled in obesity trials! Register today: https://lnkd.in/eJHee25Q
The success of obesity trials depends on more than just strong science; it relies on truly understanding patients: their motivations, their barriers to participation and the support they need to stay engaged. In our upcoming webinar, Dr. Shipra Patel joins a panel of experts to explore strategies that help sponsors reduce early drop-out rates, address the unique retention challenges of GLP-1 and metabolic trials and design protocols that work for both patients and sites. The discussion will dive into real-world strategies for understanding what drives patient engagement, from tackling placebo perception and side effects like “food noise” to integrating behavioral and mental health support. You'll also gain practical insights to streamline operational delivery, reduce site burden, and improve retention, protecting your trial's efficacy endpoints and ensuring success from screening through post-trial transitions. Register now to gain actionable strategies that make a difference in trial success: https://lnkd.in/eTVRND8J #GLP1 #PatientEngagement #ObesityTrials #ClinicalResearch #PatientRetention
-
We’re excited to welcome Ethan Rooney to Elligo Health Research as our new Chief Growth Officer! Ethan brings extensive experience in clinical trial operations, sales leadership, and supporting pharma, biotech, medtech and CRO partners across the industry to advance innovation. At Elligo, he will lead growth efforts for our Integrated Research Organization to help expand the reach of our community-based sites and research centers as well as site-based and patient-centric trial solutions. His leadership will be instrumental in broadening access to research and delivering greater value to our partners and participants. Welcome to the team, Ethan—we’re excited for what’s ahead!
-
-
Retaining participants in clinical trials takes more than coordination, it requires concierge level care. At Elligo, our global travel solutions are personalized to ease the burden on participants and caregivers alike, meeting their individual needs while supporting sponsor study success. Connect here to learn more about how we can make your participants journey easier: https://lnkd.in/efGA3fV #PatientCentric #ClinicalTrials #PatientRetention #ClinicalResearch
-
-
At Elligo, we know that FDA inspection readiness is non-negotiable, regardless of the trial model. But how prepared are you for a DCT-based inspection? In a recent webinar hosted by Clinical Leader, Elligo's Chief Medical Officer, Faith L. Holmes, M.D., and Executive Director of Compliance and Development, Jamie Chalfin , discussed the FDA inspection process, shared best practices, and offered practical takeaways for clinical teams navigating decentralized models. 👉 Watch the full on-demand webinar now: https://lnkd.in/eknVNnAB #DCT #DecentralizedTrials #ClinicalResearch
-
